Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005108 · ClinicalTrials.gov registry record · Phase 2
Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors
A Phase 2 study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT01005108 is a Phase 2 study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 120 participants.
The verdict
NCT01005108, a Phase 2 study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
Overall Objectives: The overarching goal is to compare the effectiveness of acupuncture and gabapentin to their respective placebo controls in the treatment of hot flashes in breast cancer patients. The investigators primary specific aim will focus on determining the magnitude of response to placebo acupuncture versus placebo pills on hot flashes (HFs).
Interventions
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2009-01 |
| Est. Completion | 2014-01-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01005108
The ClinicalTrials.gov registry entry for NCT01005108 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gabapentin is the first listed.
NCT01005108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01005108 about?
NCT01005108 is a clinical study titled "Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors". Overall Objectives: The overarching goal is to compare the effectiveness of acupuncture and gabapentin to their respective placebo controls in the treatment of hot flashes in breast cancer patients. The investigators primary specific aim will focus on determining the magnitude of response to placebo...
What is the current status of trial NCT01005108?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2009-01. Estimated completion is 2014-01-31.
What interventions are being tested in trial NCT01005108?
The interventions under investigation include: Gabapentin (DRUG).
Who is sponsoring clinical trial NCT01005108?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.